true
{"AlternateComparison":false,"RelatedProducts":false,"Specification":true,"FeatureBenefit":false}
No image
LifeStent™ Solo™ Vascular stents LifeStent™ Solo™ Vascular Stent System

LIFESTENT

LIFESTENT SOLO Vascular Stent System 6 mm x 200 mm (6 F, 100 cm delivery catheter)

Icon to close the modal
Contact Us
Sales
Submit a form online
Go next / move forward Icon
Modal Close Icon
Icon to close thank you modal
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Customer Care
Phone Icon
0800 917 8776
BDUK_customerservice@bd.com
Support
Go next / move forward Icon
Overview

200 mm stent length that potentially enables a single-stent solution.

Sustained effectiveness up to three years in longer lesions.  

Enhanced delivery system is designed to reduce delivery system-dependent stent compression or elongation and enhance deployment accuracy. 

FDA-approved stent for the SFA and full popliteal artery. 

Available in 6 mm and 7 mm diameters and 200 mm in length.

true
Features and Benefits
FEATURE AND BENEFIT CARDS NOT AVAILABLE
FEATURE AND BENEFIT CARDS NOT AVAILABLE
Promotional Story
false
Specification

GTIN - Each

04049519003702

1

GTIN

GTIN - Each 04049519003702 1
Electronic Instructions for Use (eIFUs)
Resources
document-icon.svg
Literature

BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.

Learn more
Training-Icon.png
Training

BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.

Learn more
true
Frequently Asked Questions
false
Related Products
RELATED PRODUCTS NOT AVAILABLE
References

1. As of December 2020

 

2. LifeStent™ Solo™ Vascular Stent Delivery System Study. A single-arm, prospective, non-randomized, multi-center study evaluating the safety and effectiveness of the LifeStent™ Solo™ in the treatment of symptomatic vascular disease of the SFA and/or proximal popliteal artery. Subjects were treated with conventional PTA followed by implantation of the LifeStent™ Vascular Stent. The LifeStent™ 5 mm diameter was not included in this trial.

3. RESILIENT I Trial, RESILIENT II Trial, E-TAGIUSS Trial, Retrospective Analysis of LifeStent® Vascular Stent Systems in the Treatment of Long-Segment Lesions, LifeStent® Vascular Stent Delivery System Study (LifeStent® 200 mm Trial),REALITY I Trial,REALITY II Trial, ETAP Trial, CONTINUUM Trial, and RELIABLE Trial. Additional trials ongoing.

Please consult Instructions for Use for product indications for use, contraindications, warnings, precautions, complications, adverse events and detailed safety information.

true
true